Ensuring Allogenic Stem Cell Acquisition Charges Are Not Included in the Inpatient Prospective Payment System (IPPS) Payment Calculation
This change request ensures that allogenic stem cell acquisition costs, reported with revenue code 0815, are not included in the IPPS payment and are deducted prior to processing through Pricer.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: May 11, 2021
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.